 Early Safety Monitoring Once 6 subjects have been enrolled and completed the first treatment cycle in Stage 1 of this study, the enrollment continuity would depend on the availability of safety data from the on-going Phase 2 study MEDI4736-MM-003 of DARA and DURVA in previously DARA-naïve patients. 